Recombinant Rat Omega-3 fatty acid receptor 1 (O3far1)

What is Omega-3 Fatty Acid Receptor 1 (O3far1) and what are its alternative nomenclatures?

Omega-3 Fatty Acid Receptor 1 (O3far1) is a G-protein coupled receptor that functions as a receptor for medium and long-chain free fatty acids, particularly omega-3 fatty acids. It is also known as G-protein coupled receptor 120 (Gpr120) and Gpr129 in some literature. The receptor signals through a G(q)/G(11)-coupled pathway and plays crucial roles in various physiological processes including inflammation modulation, lipid metabolism, and cardiovascular function . This receptor is part of the rhodopsin family of G-protein coupled receptors and participates in essential anti-inflammatory responses and insulin sensitization mechanisms .

What biological samples can be used to study O3far1 expression in rats?

O3far1 expression can be studied in various rat biological samples including:

• Serum and plasma

• Tissue homogenates (particularly from adipose tissue, colon, and macrophages)

• Cell culture supernatants from rat cell lines

• Isolated primary cells

The choice of sample depends on the specific research question. For quantitative analysis, sandwich ELISA assays can detect O3far1 with a sensitivity of approximately 0.322ng/mL and a detection range of 0.625-40ng/ml in these sample types .

What are the main functions of O3far1 in rat physiological systems?

O3far1 serves several critical physiological functions in rat models:

• Acts as the primary receptor for omega-3 fatty acids, particularly EPA and DHA

• Mediates robust anti-inflammatory effects, especially in macrophages and adipocytes

• Regulates TAK1 inhibition through a beta-arrestin 2 (ARRB2)/TAB1 dependent mechanism

• Participates in insulin signaling and glucose metabolism

• Contributes to cardiovascular regulation

• May influence taste perception for fatty acids

These functions make O3far1 a significant target in research related to metabolic disorders, inflammation-mediated conditions, and cardiovascular health .

What methodological approaches are most effective for studying O3far1 signaling pathways in rat tissue samples?

The most effective methodological approaches for studying O3far1 signaling pathways in rat tissues involve a combination of techniques:

• Tissue preparation protocol:

  • Immediate tissue collection and rinsing with cold PBS containing indomethacin (5.6 μg/mL)

  • Segmentation of tissues (particularly relevant for colon studies: proximal, transverse, distal)

  • Snap freezing in liquid nitrogen

  • Pulverization of frozen tissue followed by homogenization in cold PBS with indomethacin

  • Sonication in ice water (20s sonication, 20s cooling cycles for 3 minutes)

  • Protein concentration determination using Bradford assay

• Signaling pathway analysis:

  • Western blotting for phosphorylation states of downstream effectors

  • Immunoprecipitation to detect protein-protein interactions (particularly for beta-arrestin 2/TAB1 interactions)

  • RT-qPCR for transcriptional targets of the signaling pathway

  • Pharmacological inhibition studies to determine pathway dependencies

• Quantitative assessment:

  • ELISA-based quantification of O3far1 (detection range 0.625-40ng/ml)

  • Linear mixed effect regression models that account for tissue variability and batch effects

How do O3far1 expression patterns differ across rat tissue types, and what are the implications for experimental design?

O3far1 expression demonstrates significant tissue-specific variations that have important implications for experimental design. Based on comprehensive tissue analyses:

These expression patterns necessitate careful experimental design decisions:

• Studies focusing on metabolic effects should prioritize adipose tissue samples

• Inflammatory response studies should include macrophage isolation protocols

• Colon-based studies must account for regional variations through appropriate sectioning and statistical models that incorporate section as a factor variable

• Batch effects should be controlled for in all quantitative analyses

What are the key factors to consider when designing dietary interventions to study O3far1 in rat models?

When designing dietary interventions to study O3far1 in rat models, researchers should consider:

• Diet formulation precision:

  • Maintain constant total fat content (e.g., 34% of calories) while manipulating EPA:ω6 ratios

  • Verify fatty acid composition of experimental diets using GC-MS

  • Stabilize oils against oxidation using appropriate antioxidants (e.g., mixed tocopherols)

  • Use appropriate control diets (e.g., modified AIN93-G diet)

• Intervention timeline:

  • Allow for acclimation period (typically one week) before experimental diet introduction

  • Consider intervention duration based on endpoint measures (five weeks demonstrated measurable changes in O3far1 signaling)

  • Monitor body weight weekly to assess potential confounding effects

• Statistical design elements:

  • Implement completely randomized block designs

  • Plan for balanced analytical batches

  • Include appropriate sample sizes based on power analysis

  • Design must account for clustering within tissue sections from the same animal

• Sample collection standardization:

  • Consider whether fasting status is relevant (some studies preserve colon biology by avoiding fasting)

  • Standardize collection procedures using cold buffers with stabilizing agents

  • Implement consistent timing for tissue collection

What are the recommended approaches for making O3far1 research data more FAIR (Findable, Accessible, Interoperable, Reusable)?

To enhance the FAIR principles in O3far1 research:

• Data structure recommendations:

  • Implement standardized templates for experimental data tables

  • Include comprehensive metadata for all samples and measurements

  • Define clear ontologies for tissue types, experimental conditions, and outcomes

  • Document all processing steps from sample collection to final analysis

• Data sharing practices:

  • Deposit raw data in appropriate repositories with persistent identifiers

  • Use machine-readable formats that preserve relationships between experimental variables

  • Include detailed methodological descriptions that enable reproduction

  • Consider upstream implementation of FAIR principles during experimental design rather than attempting compliance after completion

• Integration approaches:

  • Develop data models that account for the multifactorial nature of O3far1 research

  • Implement dimensional modeling approaches similar to "bus architecture" for integrating clinical and research data

  • Use standardized identification systems for experimental samples and conditions

  • Ensure compatibility with existing bioinformatics infrastructures

What are common challenges in O3far1 detection assays and how can they be addressed?

Researchers frequently encounter several challenges when working with O3far1 detection assays:

• Sensitivity limitations:

  • Problem: Standard assays may not detect low expression levels in certain tissues

  • Solution: Employ signal amplification techniques or concentrate samples; use ELISA kits with documented sensitivity of at least 0.322ng/mL

• Cross-reactivity concerns:

  • Problem: Antibodies may cross-react with related GPCRs

  • Solution: Validate antibody specificity using positive and negative controls; consider knockout validation where possible

• Tissue heterogeneity:

  • Problem: Variable expression across tissue sections leads to inconsistent results

  • Solution: Implement consistent tissue sectioning protocols; use statistical models that account for section as a factor variable

• Batch effects:

  • Problem: Systematic variations between experimental batches

  • Solution: Use balanced designs with samples from different treatment groups in each batch; incorporate batch as a categorical variable in statistical models

• Sample degradation:

  • Problem: Rapid protein degradation affecting detection

  • Solution: Process samples immediately; add protease inhibitors; maintain cold chain throughout processing

How can researchers effectively optimize Western blotting protocols for O3far1 detection in rat tissue samples?

Optimizing Western blotting for O3far1 detection requires careful attention to several protocol elements:

• Sample preparation:

  • Homogenize tissues in RIPA buffer supplemented with phosphatase and protease inhibitors

  • Maintain samples at 4°C throughout processing

  • Determine protein concentration using Bradford assay

  • Load 30-50μg of protein per lane for optimal detection

• Electrophoresis and transfer conditions:

  • Use 10% SDS-PAGE gels for optimal separation

  • Transfer to PVDF membranes at constant voltage (100V for 60 minutes) in cold transfer buffer

  • Verify transfer efficiency with reversible protein stains before blocking

• Antibody selection and validation:

  • Test multiple antibodies targeting different epitopes of O3far1

  • Include positive controls (tissues with known high expression)

  • Include negative controls (tissues from knockout models if available)

  • Optimize primary antibody concentration (typically 1:500 to 1:2000 dilution)

  • Use secondary antibodies with minimal cross-reactivity to rat proteins

• Signal detection optimization:

  • Consider enhanced chemiluminescence systems for improved sensitivity

  • Optimize exposure times based on signal strength

  • Use digital imaging systems that allow for quantitative analysis

• Normalization approach:

  • Select appropriate housekeeping proteins based on tissue type and experimental conditions

  • Verify stability of housekeeping protein expression across experimental conditions

  • Calculate O3far1 expression relative to housekeeping proteins using densitometry

How might advanced genetic approaches enhance our understanding of O3far1 function in rat models?

Advanced genetic approaches offer promising avenues for deepening our understanding of O3far1 function:

• CRISPR/Cas9-mediated strategies:

  • Generation of tissue-specific O3far1 knockout rat models

  • Introduction of point mutations to investigate specific signaling pathways

  • Creation of reporter systems for real-time monitoring of O3far1 activity

  • Development of models with humanized O3far1 for translational research

• Transcriptomic approaches:

  • RNA-seq analysis of tissues from rats with varying O3far1 expression levels

  • Single-cell RNA sequencing to understand cell-type specific responses

  • Temporal transcriptomic profiling following omega-3 fatty acid administration

  • Integration of transcriptomic data with proteomic and metabolomic datasets

• Epigenetic investigations:

  • Characterization of epigenetic modifications affecting O3far1 expression

  • Analysis of diet-induced epigenetic changes in O3far1 regulatory regions

  • Investigation of transgenerational epigenetic effects on O3far1 function

• Systems biology integration:

  • Development of computational models that integrate O3far1 signaling with broader metabolic networks

  • Multi-omics approaches that capture comprehensive effects of O3far1 activation

  • Machine learning applications to identify patterns in complex datasets related to O3far1 function

What are emerging approaches for studying the interaction between O3far1 and other metabolic receptors in complex diseases?

Emerging approaches for investigating O3far1 interactions with other receptors include:

• Proximity labeling techniques:

  • BioID or APEX2-based approaches to identify proteins in close proximity to O3far1

  • Analysis of receptor complex formation under different dietary conditions

  • Investigation of dynamic changes in the O3far1 interactome during inflammatory responses

• Advanced imaging methodologies:

  • Super-resolution microscopy to visualize receptor co-localization

  • FRET/BRET techniques to measure direct receptor interactions

  • Live-cell imaging to track receptor trafficking following omega-3 fatty acid stimulation

• Multi-receptor signaling analysis:

  • Simultaneous monitoring of multiple receptor pathways (e.g., O3far1 and PPARs)

  • Phosphoproteomic analysis to identify convergent signaling nodes

  • Development of dual-receptor targeting strategies for metabolic diseases

• Translational research approaches:

  • Parallel studies in human and rat samples to validate conserved mechanisms

  • Development of biomarkers based on O3far1 activation status

  • Investigation of receptor polymorphisms and their impact on disease susceptibility and treatment response